For the first time, scientists have invented a liquid ink that doctors can print onto a patient’s scalp to measure brain activity. The technology, presented
CHICAGO — An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration (AMD) suggested a potential annual savings of $3,200 per patient,
Cardiorenal biotech Renibus Therapeutics has completed a Series B extension that brings its total proceeds to $72 million, securing a runway through registrational development and